SECTION 56 APPLICATION
Begin Your Process Here

Welcome! This page will allow you to review your initial eligibility and fill out the form below for consideration.

Health Canada is opening the doors for Section 56 Exemption applications for psilocybin therapy for a very select group of applicants with mental health challenges.

IMPORTANT NOTE: Health Canada has only approved Section 56 Exemptions for Palliative, End-of-Life applicants, and at this time, there have not been applications approved for Mental Health (treatment-resistant Depression, Anxiety, and PTSD). ATMA is aware that Health Canada is reviewing other options for Canadians to receive psilocybin therapy, and as such, this application process will likely change shortly. ATMA is in continual conversations with Health Canada, and we encourage you to continue with your application. We will send updates to applicants once it becomes clear of the direction Health Canada will be taking.

ATMA is a neutral collator of extant research on psilocybin. We do not promote the use of illegal drugs or encourage patients to seek Health Canada exemptions, only facilitate their self-directed efforts.

You ARE a good candidate for consideration if:

  • you are dealing with long-term chronic depression, chronic anxiety, PTSD/CPTSD for which other treatments have not been effective, including pharmaceutical medications;
  • you have an ongoing connection with a therapist that is willing to support you through the process of applying and continued support if approved. If you do not have a therapist at this time, we recommend you take the time to find one who is a good fit for you and will support you in this process before you apply.

You are NOT a good candidate if:

  • you have been diagnosed with Schizophrenia, Borderline Personality Disorder, or Bipolar Disorder;
  • you have experienced traumatic brain injury, experiencing active uncontrolled medical conditions (such as unstable angina, unstable diabetes, uncontrolled asthma/COPD) or experiencing active uncontrolled addictions. We believe that with more study, these conditions may allow for the safe use of psilocybin treatment in the future, but at this time we are not able to process applications with these conditions.

Treatments for approved applications will be offered at ATMA Journey Centers.At present, we are located in Calgary, Alberta, and will soon have locations in Ontario and British Columbia.

Please fill out the following preliminary intake form if you feel you are a good candidate based on the above parameters and we will review this preliminary application and send next steps for the application process.

Please click submit and we will be in touch about your next steps.

Scroll to Top